Venetoclax + Low-Dose Cytarabine in Elderly Patients With Untreated AML

Slideset - Early-phase study suggests promise of venetoclax plus low-dose cytarabine in untreated elderly patients with acute myeloid leukemia.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research